Medical Devices
Dermatology Devices Market Size, 2024-2033
USD Billion
The figures are in the full report. Request a free sample ↗
Market overview
| Study Period | 2024 - 2033 |
|---|---|
| Historic Year | 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 - 2033 |
| Market Size (Base Year) | USD 9.0 Billion |
| Market Size (Forecast Year) | USD 15.5 Billion |
| Growth Rate (CAGR) | 7.0 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Pages from the sample report. Figures are shown as XX here; the full report has them.
See the full sample: Request a free sample ↗
This report covers the dermatology devices market: medical and aesthetic devices used to diagnose, monitor and treat skin, hair and nail conditions and for aesthetic skin and body treatments, including dermatoscopes, microscopes, skin imaging and biopsy devices, and lasers, light therapy, radiofrequency, electrosurgical, liposuction, microdermabrasion and cryotherapy devices, used in hospitals, clinics and other settings. The market is valued at manufacturers' selling prices, including consumables.
Dermatology devices range from handheld dermatoscopes used to examine moles to lasers used for hair removal, skin resurfacing and treating vascular lesions.
Rising rates of skin cancer and the push for earlier detection are increasing the use of dermatoscopes, skin imaging and artificial intelligence tools that help doctors assess moles and lesions.
Ageing populations and growing demand for non-surgical aesthetic treatments such as hair removal, skin rejuvenation and body contouring, especially in Asia, support sales of lasers and energy-based devices.
However, devices are expensive, many clinics depend on financing that has become costlier, consumer spending on aesthetic treatments is sensitive to the economy, and regulatory requirements and tariffs add costs.
The global Dermatology Devices market is mainly classified based on product type, application and end user. By product type, the market is segmented into diagnostic devices (dermatoscopes, microscopes, other imaging devices and biopsy devices) and treatment devices (light therapy devices, lasers, electrosurgical equipment, liposuction devices, microdermabrasion devices and cryotherapy devices). By application, it covers diagnostic applications, including skin cancer diagnosis, and treatment applications, including hair removal, skin rejuvenation, acne, psoriasis and tattoo removal, wrinkle removal and resurfacing, body contouring, cellulite reduction and vascular and pigmented lesion removal. By end user, it is divided into hospitals, clinics and others.
Treatment devices account for most of the market, led by lasers and other energy-based devices. Diagnostic devices are smaller but growing quickly as skin imaging and AI tools spread.
Hair removal, skin rejuvenation and body contouring are the largest treatment applications, and clinics, including dermatology and aesthetic practices, are the largest end users.
North America is the largest market, led by the United States, with high spending on aesthetic treatments and skin cancer screening, although clinic purchases slowed as financing costs rose.
Europe is the second-largest market. Asia-Pacific is expected to grow fastest, led by strong demand for aesthetic treatments in China, South Korea and Japan and by local device makers, while South America, led by Brazil, and the Middle East and Africa are smaller but growing markets.
Some of the major competitors in the global Dermatology Devices market include Candela Medical, BTL Industries, InMode Ltd., Sisram Medical (Alma Lasers), Lumenis Be Ltd., Cynosure Lutronic, Solta Medical (Bausch Health), Cutera, Inc., AbbVie (Allergan Aesthetics, CoolSculpting), Sciton, Inc., Venus Concept, Classys Inc., Jeisys Medical, HEINE Optotechnik, Canfield Scientific, and FotoFinder Systems.
The Dermatology Devices market is fragmented. Candela, BTL, InMode, Alma (Sisram), Lumenis, Cynosure Lutronic, Solta and Cutera are leading makers of aesthetic energy-based devices, AbbVie's Allergan Aesthetics leads in fat-freezing, South Korean makers such as Classys and Jeisys are growing, and HEINE, Canfield and FotoFinder are known for dermatoscopes and skin imaging.
Ans: The Dermatology Devices market was valued at USD 9.0 billion in 2025 and is projected to reach USD 15.5 billion by 2033, at a CAGR of 7.0% during the forecast period.
Ans: AI-assisted skin cancer detection, total-body imaging, combination energy-based platforms, home-use devices and aesthetic treatments in Asia are major opportunities.
Ans: Rising skin cancer screening and growing demand for non-surgical aesthetic treatments are the main growth drivers.
Ans: North America is expected to have the largest share, while Asia-Pacific is expected to grow fastest.
Ans: Treatment devices, led by lasers and energy-based devices, are expected to dominate the market.
Many aesthetic clinics finance laser and energy-based devices through loans and leases, and high interest rates since 2023 have slowed purchases, particularly in the United States. One of the leading aesthetic device makers went through a debt restructuring in 2025, while others reported falling or slower sales in North America.
In September 2025 the US government opened a national security investigation into imports of medical equipment and devices, which could lead to tariffs on imported aesthetic and diagnostic devices, many of which are made in Israel, Europe and South Korea.
Demand has held up better in Asia-Pacific and Europe, and makers are relying more on consumables and service revenue and on injectables and other treatments sold to the same clinics.
This report assumes a gradual recovery in clinic purchases as financing costs ease, and treats tariffs and weak consumer spending on aesthetic treatments as the main risks.
Backed by 1 million+ hours of research experience across the industries we cover.
Domains covered
Countries covered
Committed to timely delivery
Projects delivered